Showing results (1951-1960 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|September 3, 2014
FHL2 regulates hematopoietic stem cell functions under stress conditionsY Hou, X Wang, L Li, et al.
Leukemia|September 3, 2014
Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myelomaY Yang, Y Chen, M N Saha, et al.
Leukemia|April 30, 2016
Modeling BCR-ABL and MLL-AF9 leukemia in a human bone marrow-like scaffold-based xenograft modelP Sontakke, M Carretta, J Jaques, et al.
Leukemia|May 7, 2016
Mesenchymal stromal cell-derived extracellular vesicles rescue radiation damage to murine marrow hematopoietic cellsS Wen, M Dooner, Y Cheng, et al.
Leukemia|September 4, 2020
The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signallingAntoine David, Simone Zocchi, Alexis Talbot, et al.
Leukemia|November 7, 2020
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in micePaolo Sportoletti, Daniele Sorcini, Anna G Guzman, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Leukemia|November 5, 2020
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoChristoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, et al.
Leukemia|May 3, 2022
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDSMonika Kaisrlikova, Jitka Vesela, David Kundrat, et al.
Leukemia|May 11, 2018
UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein responseL N Huiting, Y Samaha, G L Zhang, et al.
Pageof 963